Prosecution Insights
Prosecution Insights
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (20%) |
| Double-patenting only | 1 (20%) |
| Double-patenting + other | 1 (20%) |
| No statute on record | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STEELE, AMBER D | 1 | 59.1% | +9.1% |
| KRISHNAN, GANAPATHY | 1 | 52.2% | +0.0% |
| LU, FRANK WEI MIN | 1 | 63.0% | +66.3% |
| WILSON, MICHAEL C | 1 | 41.7% | +17.6% |
| SITTON, JEHANNE SOUAYA | 1 | 52.9% | +47.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16760522 | CANCER DETECTION, CLASSIFICATION, PROGNOSTICATION, THERAPY PREDICTION AND THERAPY MONITORING USING METHYLOME ANALYSIS | SITTON, JEHANNE SOUAYA | 34d |
| 17825784 | TOOLS AND METHODS FOR USING CELL DIVISION LOCI TO CONTROL PROLIFERATION OF CELLS | WILSON, MICHAEL C | 79d |
| 18059370 | METHODS OF CAPTURING CELL-FREE METHYLATED DNA AND USES OF SAME | LU, FRANK WEI MIN | — |
| Art Unit | Apps |
|---|---|
| 1658 | 1 |
| 1693 | 1 |
| 1683 | 1 |
| 1638 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18426877 | Treatment of Homologous Recombination Deficient Cancers | STEELE, AMBER D | 1658 | Other | Final Rejection | 4d overdue | Pending | Jan 30, 2024 |
| 18284614 | COMBINATION THERAPIES INCLUDING MYT1 INHIBITORS | KRISHNAN, GANAPATHY | 1693 | Other | Non-Final OA | 15d overdue | Pending | Sep 28, 2023 |
| 18059370 | METHODS OF CAPTURING CELL-FREE METHYLATED DNA AND USES OF SAME | LU, FRANK WEI MIN | 1683 | DP | Non-Final OA | — | Pending | Nov 28, 2022 |
| 17825784 | TOOLS AND METHODS FOR USING CELL DIVISION LOCI TO CONTROL PROLIFERATION OF CELLS | WILSON, MICHAEL C | 1638 | DPOther | Non-Final OA | 79d | Pending | May 26, 2022 |
| 16760522 | CANCER DETECTION, CLASSIFICATION, PROGNOSTICATION, THERAPY PREDICTION AND THERAPY MONITORING USING METHYLOME ANALYSIS | SITTON, JEHANNE SOUAYA | 1682 | §103 | Final Rejection | 34d | Pending | Apr 30, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial